Teva Pharmaceutical (Israel) Performance
TEVA Stock | ILA 4,933 48.00 0.98% |
On a scale of 0 to 100, Teva Pharmaceutical holds a performance score of 10. The entity has a beta of -0.44, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Teva Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Teva Pharmaceutical is likely to outperform the market. Please check Teva Pharmaceutical's potential upside, semi variance, and the relationship between the value at risk and downside variance , to make a quick decision on whether Teva Pharmaceutical's existing price patterns will revert.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharmaceutical Industries are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Teva Pharmaceutical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow | 2.2 B |
Teva |
Teva Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 434,200 in Teva Pharmaceutical Industries on January 28, 2024 and sell it today you would earn a total of 59,100 from holding Teva Pharmaceutical Industries or generate 13.61% return on investment over 90 days. Teva Pharmaceutical Industries is generating 0.2745% of daily returns and assumes 1.97% volatility on return distribution over the 90 days horizon. Simply put, 17% of stocks are less volatile than Teva, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Teva Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Teva Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Teva Pharmaceutical Industries, and traders can use it to determine the average amount a Teva Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1394
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | TEVA | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.97 actual daily | 17 83% of assets are more volatile |
Expected Return
0.27 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Teva Pharmaceutical is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Teva Pharmaceutical by adding it to a well-diversified portfolio.
Teva Pharmaceutical Fundamentals Growth
Teva Stock prices reflect investors' perceptions of the future prospects and financial health of Teva Pharmaceutical, and Teva Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Teva Stock performance.
Return On Equity | -0.24 | |||
Return On Asset | 0.0363 | |||
Profit Margin | (0.16) % | |||
Operating Margin | 0.18 % | |||
Current Valuation | 102.13 B | |||
Shares Outstanding | 1.11 B | |||
Price To Book | 1.18 X | |||
Price To Sales | 2.32 X | |||
Revenue | 14.93 B | |||
EBITDA | (791 M) | |||
Cash And Equivalents | 2.44 B | |||
Cash Per Share | 2.21 X | |||
Total Debt | 19.1 B | |||
Debt To Equity | 2.26 % | |||
Book Value Per Share | 7.11 X | |||
Cash Flow From Operations | 1.59 B | |||
Earnings Per Share | (0.56) X | |||
Total Asset | 44.01 B | |||
Retained Earnings | 14.99 B | |||
Current Asset | 18.4 B | |||
Current Liabilities | 13.01 B | |||
About Teva Pharmaceutical Performance
To evaluate Teva Pharmaceutical Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Teva Pharmaceutical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Teva Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Teva Pharmaceutical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Teva's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. TEVA PHARMA is traded on Tel Aviv Stock Exchange in Israel.Things to note about Teva Pharmaceutical performance evaluation
Checking the ongoing alerts about Teva Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Teva Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.The company reported the revenue of 14.93 B. Net Loss for the year was (2.35 B) with profit before overhead, payroll, taxes, and interest of 6.97 B. |
- Analyzing Teva Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Teva Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Teva Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Teva Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Teva Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Teva Pharmaceutical's stock. These opinions can provide insight into Teva Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharmaceutical Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Teva Stock analysis
When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |